News for Catalyst Biosciences, Inc. (CBIO)

News for Catalyst Biosciences, Inc.
Date Headline
Jul 06, 2017 08:01 AM Financial Milestone Achieved in Catalyst’s Subcutaneous Factor IX Program
Jun 28, 2017 08:00 AM Catalyst Biosciences’ Factor IX Granted Orphan Drug Designation in Europe
Jun 26, 2017 08:01 AM Catalyst Biosciences Announces Achievement of Stable Normal Factor IX Blood Levels in a Preclinical Subcutaneous Dosing Model
Jun 14, 2017 08:01 AM Catalyst Biosciences and ISU Abxis Complete Dosing of First Patient Cohort in Hemophilia B Clinical Trial
Jun 08, 2017 08:00 AM Catalyst Biosciences Announces Presentations on its Next-Generation Subcutaneous Hemophilia Product Candidates at the 2017 International Society on Thrombosis and Haemostasis (ISTH) Meeting
Jun 01, 2017 08:00 AM Today's Research Reports on Stocks to Watch: Catalyst Biosciences and MEI Pharma
May 31, 2017 08:00 AM Catalyst Biosciences’ Factor IX Recommended for Orphan Drug Designation in Europe
May 24, 2017 10:03 AM Catalyst Biosciences, Inc. :CBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
May 11, 2017 08:28 AM Catalyst Biosciences reports 1Q loss
May 11, 2017 08:01 AM Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update